Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia

Aim. To analyze risk factors for sarcopenia in atherosclerosis involvement of target organs in patients with type 2 diabetes (T2D).Material and methods. The study included 84 patients with T2D, divided into groups according to the 2019 criteria of the European Working Group on Sarcopenia in Older Pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. G. Samoilova, M. V. Matveeva, E. A. Khoroshunova, D. V. Podchinenova, L. L. Maksimova, G. G. Gorbach, A. B. Trivozhenko, V. A. Avkhimenko
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2024-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3655
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699390749409280
author Yu. G. Samoilova
M. V. Matveeva
E. A. Khoroshunova
D. V. Podchinenova
L. L. Maksimova
G. G. Gorbach
A. B. Trivozhenko
V. A. Avkhimenko
author_facet Yu. G. Samoilova
M. V. Matveeva
E. A. Khoroshunova
D. V. Podchinenova
L. L. Maksimova
G. G. Gorbach
A. B. Trivozhenko
V. A. Avkhimenko
author_sort Yu. G. Samoilova
collection DOAJ
description Aim. To analyze risk factors for sarcopenia in atherosclerosis involvement of target organs in patients with type 2 diabetes (T2D).Material and methods. The study included 84 patients with T2D, divided into groups according to the 2019 criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). All patients were surveyed using a 36-item short-form health survey (SF-36), Sarcopenia and Quality of Life (SarQoL), Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), grip test, 4-meter walk test, bioelectrical impedance analysis, 24-hour blood pressure monitoring and cardiac ultrasound. Differences were considered significant at p<0,05.Results. Patients with sarcopenia have lower levels of fat, muscle, cell mass, appendicular mass index, fluid, protein, and minerals. In the group with sarcopenia, higher levels of total cholesterol, low-density lipoprotein cholesterol, glycated hemoglobin, and hypocalcemia were detected. Triglyceride levels were high in those with presarcopenia. In the same group, unstable blood pressure, increased myocardial mass and severe lower limb atherosclerosis were recorded.Conclusion. Sarcopenia is one of the important medical and social problems and is accompanied by unfavorable outcomes. The combination of sarcopenia and T2D can contribute to the rapid development of macro- and microangiopathy and increase the cardiovascular risk.
format Article
id doaj-art-97fc39a98aa446fcbaa39d71be12f7af
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2024-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-97fc39a98aa446fcbaa39d71be12f7af2025-08-20T03:18:35Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252024-02-0123110.15829/1728-8800-2024-36552810Cardiometabolic risk factors in patients with type 2 diabetes and sarcopeniaYu. G. Samoilova0M. V. Matveeva1E. A. Khoroshunova2D. V. Podchinenova3L. L. Maksimova4G. G. Gorbach5A. B. Trivozhenko6V. A. Avkhimenko7Siberian State Medical UniversitySiberian State Medical UniversitySiberian State Medical University; Federal Siberian Research Clinical CenterSiberian State Medical UniversityFederal Siberian Research Clinical CenterFederal Siberian Research Clinical CenterFederal Siberian Research Clinical Center; Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical TechnologiesFederal Siberian Research Clinical CenterAim. To analyze risk factors for sarcopenia in atherosclerosis involvement of target organs in patients with type 2 diabetes (T2D).Material and methods. The study included 84 patients with T2D, divided into groups according to the 2019 criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). All patients were surveyed using a 36-item short-form health survey (SF-36), Sarcopenia and Quality of Life (SarQoL), Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), grip test, 4-meter walk test, bioelectrical impedance analysis, 24-hour blood pressure monitoring and cardiac ultrasound. Differences were considered significant at p<0,05.Results. Patients with sarcopenia have lower levels of fat, muscle, cell mass, appendicular mass index, fluid, protein, and minerals. In the group with sarcopenia, higher levels of total cholesterol, low-density lipoprotein cholesterol, glycated hemoglobin, and hypocalcemia were detected. Triglyceride levels were high in those with presarcopenia. In the same group, unstable blood pressure, increased myocardial mass and severe lower limb atherosclerosis were recorded.Conclusion. Sarcopenia is one of the important medical and social problems and is accompanied by unfavorable outcomes. The combination of sarcopenia and T2D can contribute to the rapid development of macro- and microangiopathy and increase the cardiovascular risk.https://cardiovascular.elpub.ru/jour/article/view/3655type 2 diabetessarcopeniahypertensiondyslipidemiaperipheral artery disease
spellingShingle Yu. G. Samoilova
M. V. Matveeva
E. A. Khoroshunova
D. V. Podchinenova
L. L. Maksimova
G. G. Gorbach
A. B. Trivozhenko
V. A. Avkhimenko
Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
Кардиоваскулярная терапия и профилактика
type 2 diabetes
sarcopenia
hypertension
dyslipidemia
peripheral artery disease
title Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
title_full Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
title_fullStr Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
title_full_unstemmed Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
title_short Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
title_sort cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
topic type 2 diabetes
sarcopenia
hypertension
dyslipidemia
peripheral artery disease
url https://cardiovascular.elpub.ru/jour/article/view/3655
work_keys_str_mv AT yugsamoilova cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT mvmatveeva cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT eakhoroshunova cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT dvpodchinenova cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT llmaksimova cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT gggorbach cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT abtrivozhenko cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia
AT vaavkhimenko cardiometabolicriskfactorsinpatientswithtype2diabetesandsarcopenia